UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center

The journal of clinical endocrinology and metabolism, 2020-03, Vol.105 (3), p.e172-e180

2020

Link zum Volltext

Verfügbarkeit prüfen

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities

International journal of molecular sciences, 2021-03, Vol.22 (6), p.3117

2021

Link zum Volltext

Verfügbarkeit prüfen

Follow-up dei pazienti e dei carrier di mutazioni del gene MEN2

L'Endocrinologo, 2022, Vol.23 (Suppl 1), p.26-28

2022

Link zum Volltext

Verfügbarkeit prüfen

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing

iScience, 2019-10, Vol.20, p.324-336

2019

Link zum Volltext

Verfügbarkeit prüfen

Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations

Genes, 2019-09, Vol.10 (9), p.698

2019

Link zum Volltext

Verfügbarkeit prüfen

Gestione del carcinoma tiroideo in età pediatrica

L'Endocrinologo, 2024, Vol.25 (1), p.68-74

2024

Link zum Volltext

Verfügbarkeit prüfen

Fifty Years After the First Description, MEN 2B Syndrome Diagnosis Is Still Late: Descriptions of Two Recent Cases

The journal of clinical endocrinology and metabolism, 2019-07, Vol.104 (7), p.2520-2526

2019

Link zum Volltext

Verfügbarkeit prüfen

Thyroid cancer and COVID-19: experience at one single thyroid disease referral center

Endocrine, 2021-05, Vol.72 (2), p.332-339

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma

Cancers, 2020-12, Vol.13 (1), p.94

2020

Link zum Volltext

Verfügbarkeit prüfen

Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response

Frontiers in endocrinology (Lausanne), 2023-04, Vol.14, p.1133958-1133958

2023

Link zum Volltext

Verfügbarkeit prüfen

Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia

Cancers, 2021-11, Vol.13 (21), p.5554

2021

Link zum Volltext

Verfügbarkeit prüfen

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

European journal of endocrinology, 2010-08, Vol.163 (2), p.301

2010

Link zum Volltext

Verfügbarkeit prüfen

Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer

European thyroid journal, 2022-12, Vol.11 (6), p.1-10

2022

Link zum Volltext

Verfügbarkeit prüfen

RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency

Genes, 2020-12, Vol.12 (1), p.35

2020

Link zum Volltext

Verfügbarkeit prüfen

Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?

International journal of cancer, 2020-11, Vol.147 (10), p.2838-2846

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study

The journal of clinical endocrinology and metabolism, 2008-03, Vol.93 (3), p.682-687

2008

Link zum Volltext

Verfügbarkeit prüfen

Ca19.9 Positivity and Doubling Time Are Prognostic Factors of Mortality in Patients with Advanced Medullary Thyroid Cancer with No Evidence of Structural Disease Progression According to Response Evaluation Criteria in Solid Tumors

Thyroid (New York, N.Y.), 2021-07, Vol.31 (7), p.1050

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Evolution of Sporadic Medullary Thyroid Carcinoma With Biochemical Incomplete Response After Initial Treatment

The journal of clinical endocrinology and metabolism, 2023-07, Vol.108 (8), p.e613-e622

2023

Link zum Volltext

Verfügbarkeit prüfen

Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response

Endocrine-related cancer, 2020-02, Vol.27 (2), p.97-110

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of advanced thyroid cancer with targeted therapies: ten years of experience

Endocrine-related cancer, 2016-04, Vol.23 (4), p.R185-R205

2016

Link zum Volltext

Verfügbarkeit prüfen

Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series

Thyroid (New York, N.Y.), 2013-01, Vol.23 (1), p.50

2013

Link zum Volltext

Verfügbarkeit prüfen

Are the Clinical and Pathological Features of Differentiated Thyroid Carcinoma Really Changed over the Last 35 Years? Study on 4187 Patients from a Single Italian Institution to Answer this Question

The journal of clinical endocrinology and metabolism, 2010-04, Vol.95 (4), p.1516-1527

2010

Link zum Volltext

Verfügbarkeit prüfen

New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations

Journal of medical genetics, 2016-11, Vol.53 (11), p.729-734

2016

Link zum Volltext

Verfügbarkeit prüfen

The Timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center

The journal of clinical endocrinology and metabolism, 2012-02, Vol.97 (2), p.426-435

2012

Link zum Volltext

Verfügbarkeit prüfen

RET Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center

The journal of clinical endocrinology and metabolism, 2007-12, Vol.92 (12), p.4725-4729

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(36)
Endocrinology & Metabolism
(30)
Humans
(29)
Female
(22)
Male
(22)
Adult
(20)
Thyroid Cancer
(18)
Middle Aged
(17)
Thyroid Neoplasms - Genetics
(15)
Thyroid Neoplasms - Pathology
(15)
Aged
(14)
Carcinoma, Medullary - Genetics
(11)
Endocrinology
(11)
Proto-Oncogene Proteins C-Ret - Genetics
(11)
Young Adult
(10)
Aged, 80 And Over
(9)
Mutation
(9)
Ret
(9)
Calcitonin
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities

Follow-up dei pazienti e dei carrier di mutazioni del gene MEN2

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing

Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations

Gestione del carcinoma tiroideo in età pediatrica

Fifty Years After the First Description, MEN 2B Syndrome Diagnosis Is Still Late: Descriptions of Two Recent Cases

Thyroid cancer and COVID-19: experience at one single thyroid disease referral center

Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma

Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response

Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer

RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency

Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?

Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study

Ca19.9 Positivity and Doubling Time Are Prognostic Factors of Mortality in Patients with Advanced Medullary Thyroid Cancer with No Evidence of Structural Disease Progression According to Response Evaluation Criteria in Solid Tumors

Clinical Evolution of Sporadic Medullary Thyroid Carcinoma With Biochemical Incomplete Response After Initial Treatment

Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response

Treatment of advanced thyroid cancer with targeted therapies: ten years of experience

Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series

Are the Clinical and Pathological Features of Differentiated Thyroid Carcinoma Really Changed over the Last 35 Years? Study on 4187 Patients from a Single Italian Institution to Answer this Question

New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations

The Timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center

RET Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center

Suchergebnisse filtern